BillionToOne, Inc. (BLLN) vs Personalis, Inc. (PSNL)
- BillionToOne, Inc. BLLN 98.06 −4.55%
- Personalis, Inc. PSNL 15.65 −1.76%
BillionToOne, Inc. and Personalis, Inc. are both Diagnostics & Research companies. BillionToOne, Inc. is the larger, with a market value of $4.9B against $1.7B — 2.9× the size. Personalis, Inc. has negative trailing earnings, so its P/E is not meaningful; BillionToOne, Inc. trades at 95.0×. BillionToOne, Inc. has the higher net margin (8.35% vs −153.8%) and the higher return on invested capital (34.1% vs −317.5%). Across the 16 metrics below, BillionToOne, Inc. leads on 14 and Personalis, Inc. on 2.
Valuation
Profitability
| Metric | BLLN | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 71.27% | 12.69% | 50.89% |
| Operating margin | 10.90% | (164.07%) | (8.57%) |
| Net margin | 8.35% | (153.84%) | (6.37%) |
| Free cash flow margin | 8.35% | (144.76%) | 0.00% |
| Return on equity | 23.27% | (50.32%) | (2.92%) |
| Return on assets | 9.09% | (37.55%) | (6.71%) |
| Return on invested capital | 34.10% | (317.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack